サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1555617

膜式酸素供給装置の世界市場：産業分析、規模、シェア、成長、動向、予測（2024～2032年）

Membrane Oxygenators Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
膜式酸素供給装置の世界市場：産業分析、規模、シェア、成長、動向、予測（2024～2032年）
出版日: 2024年09月09日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の膜式酸素供給装置市場に関する詳細な調査を出版し、市場促進要因・動向・機会・課題など、主要な市場力学に関する広範な分析を提供しました。当レポートでは、市場の構造と将来の軌道に関する詳細な洞察を提示しています。

主な洞察

  • 膜式酸素供給装置の市場規模（2024年）：1億4,210万米ドル
  • 市場予測金額（2033年）：1億6,600万米ドル
  • 世界市場成長率（CAGR 2024～2033年）：2.0%

膜式酸素供給装置市場：調査範囲

膜式酸素供給装置は、呼吸不全患者のガス交換を促進する能力により、クリティカルケアや心臓手術での使用が増加しています。これらの装置は、体外生命維持装置（ECLS）および体外膜酸素化（ECMO）システムにおいて重要な役割を果たしており、ヘルスケア環境において不可欠なものとなっています。市場の主な原動力は、呼吸器疾患や心臓疾患の罹患率の上昇、ECMO手技に対する需要の高まり、さまざまな地域におけるヘルスケアインフラの進歩です。

市場促進要因：

世界の膜式酸素供給装置市場は、いくつかの重要な要因によって活性化されています。これらには、高度な酸素供給システムの使用を必要とする慢性呼吸器疾患や心血管系疾患の有病率の増加が含まれます。さらに、クリティカルケア環境における救命介入としてECMOの受け入れが拡大していることも、市場成長に大きく寄与しています。膜式酸素供給装置の設計における技術的進歩や、新生児・小児医療におけるこれらのシステムの採用増加も、市場拡大をさらに後押ししています。

市場抑制要因：

有望な成長見通しとは裏腹に、膜式酸素供給装置市場は一定の課題に直面しています。ECMOの手順や機器に関連する高額なコストは、特に発展途上国における普及の妨げとなる可能性があります。さらに、これらのシステムは複雑であり、操作には専門の医療従事者が必要であることも、市場参入の障壁となっています。特定の地域ではECMOとその応用に関する認知度が低いことも、市場の成長を制限しています。

市場機会：

膜式酸素供給装置市場は、継続的な技術革新とさまざまなヘルスケア環境におけるECMOシステムの使用拡大が大きな成長機会をもたらしています。ポータブルでユーザーフレンドリーな酸素供給装置の開発により、救急医療や在宅医療の現場におけるこれらの装置へのアクセス性が高まると予想されます。さらに、高度な医療介入による患者の転帰改善への注目の高まりは、特にヘルスケアインフラが発展しつつある新興市場において、市場成長の新たな道を開く。

本レポートで扱う主な質問

  • 世界の膜式酸素供給装置市場を牽引する主な要因は何か？
  • 膜式酸素供給装置の需要が最も高い地域はどこか？
  • 技術進歩は膜式酸素供給装置市場にどのような影響を与えているか？
  • 膜式酸素供給装置市場の主要企業はどこか、また、市場ポジションを維持するためにどのような戦略をとっているのか？
  • 膜式酸素供給装置市場の新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類
  • 市場の定義/範囲/制限

第3章 市場背景

  • 市場力学
  • シナリオ予測
  • 規制状況

第4章 世界の膜式酸素供給装置市場分析

  • 過去の市場規模金額（100万米ドル）分析、2019～2023年
  • 現在および将来の市場規模金額（100万米ドル）予測、2024～2032年
    • 前年比成長動向分析
    • 絶対的収益機会

第5章 世界の膜式酸素供給装置市場分析：製品タイプ別

  • イントロダクション/主な調査結果
  • 過去の市場規模金額（100万米ドル）分析、製品タイプ別、2019～2023年
  • 現在および将来の市場規模金額（100万米ドル）分析と予測、製品タイプ別、2024～2032年
    • 中空糸膜酸素供給装置
    • 平膜酸素供給装置
  • 前年比成長動向分析、製品タイプ別、2019～2023年
  • 絶対的収益機会、製品タイプ別、2024～2032年

第6章 世界の膜式酸素供給装置市場分析：年齢層別

  • イントロダクション/主な調査結果
  • 過去の市場規模金額（100万米ドル）分析、年齢層別、2019～2023年
  • 現在および将来の市場規模金額（100万米ドル）分析と予測、年齢層別、2024～2032年
    • 新生児
    • 小児
    • 大人
  • 前年比成長動向分析、年齢層別、2019～2023年
  • 絶対的収益機会、年齢層別、2024～2032年

第7章 世界の膜式酸素供給装置市場分析：用途別

  • イントロダクション/主な調査結果
  • 過去の市場規模金額（100万米ドル）分析、用途別、2019～2023年
  • 現在および将来の市場規模金額（100万米ドル）分析と予測、用途別、2024～2032年
    • 呼吸器
      • 呼吸不全
      • 肺塞栓症
      • 急性呼吸促拍症候群
      • 肺炎
      • COVID-19
    • 心臓
      • 急性心筋梗塞
      • 心筋炎
      • 移植後合併症
      • 非代償性心筋症
      • 心原性ショック
    • ECPR
  • 前年比成長動向分析、用途別、2019～2023年
  • 絶対的収益機会、用途別、2024～2032年

第8章 世界の膜式酸素供給装置市場分析：地域別

  • イントロダクション/主な調査結果
  • 過去の市場規模金額（100万米ドル）分析、地域別、2019～2023年
  • 現在および将来の市場規模金額（100万米ドル）分析と予測、地域別、2024～2032年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力分析：地域別

第9章 北米の膜式酸素供給装置市場分析：国別

第10章 ラテンアメリカの膜式酸素供給装置市場分析：国別

第11章 欧州の膜式酸素供給装置市場分析：国別

第12章 東アジアの膜式酸素供給装置市場分析：国別

第13章 南アジアの膜式酸素供給装置市場分析：国別

第14章 オセアニアの膜式酸素供給装置市場分析：国別

第15章 中東・アフリカの膜式酸素供給装置市場分析：国別

第16章 主要国の膜式酸素供給装置市場分析

  • 米国
  • カナダ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • ドイツ
  • イタリア
  • フランス
  • 英国
  • スペイン
  • ロシア
  • ベネルクス
  • 中国
  • 日本
  • 韓国
  • インド
  • タイ
  • マレーシア
  • インドネシア
  • オーストラリア
  • ニュージーランド
  • GCC諸国

第17章 市場構造分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 主要企業の市場シェア分析

第18章 競合分析

  • 競合の詳細
    • MicroPort Scientific Corporation
    • Nipro Medical Corporation
    • Medtronic
    • Fresenius SE &Co KGaA
    • Terumo Medical Corporation
    • Getinge AB

第19章 使用される仮定と頭字語

第20章 調査手法

目次
Product Code: PMRREP33254

Persistence Market Research has recently published a detailed report on the global Membrane Oxygenators Market, offering an extensive analysis of key market dynamics, including drivers, trends, opportunities, and challenges. The report presents in-depth insights into the structure of the market and its future trajectory.

Key Insights:

  • Membrane Oxygenators Market Size (2024E): USD 142.1 Mn
  • Projected Market Value (2033F): USD 166 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 2.0%

Membrane Oxygenators Market - Report Scope:

Membrane oxygenators are increasingly being used in critical care and cardiac surgeries due to their ability to facilitate gas exchange for patients with respiratory failure. These devices play a vital role in extracorporeal life support (ECLS) and extracorporeal membrane oxygenation (ECMO) systems, making them indispensable in healthcare settings. The market is primarily driven by the rising incidence of respiratory and cardiac disorders, the growing demand for ECMO procedures, and advancements in healthcare infrastructure across various regions.

Market Growth Drivers:

The global membrane oxygenators market is fueled by several important factors. These include the increasing prevalence of chronic respiratory and cardiovascular diseases, which necessitate the use of advanced oxygenation systems. Additionally, the growing acceptance of ECMO as a lifesaving intervention in critical care settings is a major contributor to market growth. Technological advancements in membrane oxygenator design and the rising adoption of these systems in neonatal and pediatric care further support market expansion.

Market Restraints:

Despite its promising growth prospects, the membrane oxygenators market faces certain challenges. High costs associated with ECMO procedures and devices can hinder their widespread adoption, particularly in developing countries. Furthermore, the complexity of these systems and the need for specialized healthcare professionals to operate them add to the barriers to market entry. Limited awareness about ECMO and its applications in certain regions also restricts market growth.

Market Opportunities:

The membrane oxygenators market presents significant growth opportunities driven by ongoing technological innovations and the expanding use of ECMO systems across various healthcare settings. The development of portable and user-friendly oxygenators is expected to increase the accessibility of these devices in emergency and home care settings. Moreover, the rising focus on improving patient outcomes through advanced medical interventions opens up new avenues for market growth, particularly in emerging markets where healthcare infrastructure is evolving.

Key Questions Answered in the Report:

  • What are the main factors driving the global membrane oxygenators market?
  • Which regions are witnessing the highest demand for membrane oxygenators?
  • How are technological advancements impacting the membrane oxygenators market?
  • Who are the leading players in the membrane oxygenators market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the membrane oxygenators market?

Competitive Intelligence and Business Strategy:

Leading players in the global membrane oxygenators market, such as Medtronic, Terumo Cardiovascular Systems, and Getinge AB, are focusing on innovation, product development, and strategic partnerships to stay competitive. These companies are investing in research and development to enhance device efficiency, improve patient outcomes, and expand their product portfolios. Collaborations with healthcare institutions and the introduction of cost-effective solutions for critical care are key strategies driving market growth. Additionally, meeting stringent regulatory requirements and maintaining high product quality remain priorities for companies in this space, ensuring sustained growth in the global membrane oxygenators market.

Key Companies Profiled:

  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Medtronic
  • Fresenius SE & Co KGaA
  • Terumo Medical Corporation
  • Getinge AB

Market Segments Covered in Membrane Oxygenators Market Analysis

By Type

  • Hollow Fiber Membrane Oxygenators
  • Flat Sheet Membrane Oxygenators

By Age Group

  • Neonates
  • Pediatrics
  • Adults

By Application

  • Respiratory
  • Cardiac
  • ECPR

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa(MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Regulatory Landscape
    • 3.3.1. By Key Regions
    • 3.3.2. By Key Countries

4. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2024-2032
    • 5.3.1. Hollow Fiber Membrane Oxygenators
    • 5.3.2. Flat Sheet Membrane Oxygenators
  • 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product Type, 2024-2032

6. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Age Group

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Age Group, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Age Group, 2024-2032
    • 6.3.1. Neonates
    • 6.3.2. Pediatrics
    • 6.3.3. Adults
  • 6.4. Y-o-Y Growth Trend Analysis By Age Group, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Age Group, 2024-2032

7. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2024-2032
    • 7.3.1. Respiratory
      • 7.3.1.1. Respiratory failure
      • 7.3.1.2. Pulmonary embolism
      • 7.3.1.3. Acute respiratory distress syndrome
      • 7.3.1.4. Pneumonia
      • 7.3.1.5. COVID-19
    • 7.3.2. Cardiac
      • 7.3.2.1. Acute myocardial infarction
      • 7.3.2.2. Myocarditis
      • 7.3.2.3. Post-transplant complications
      • 7.3.2.4. Decompensated cardiomyopathy
      • 7.3.2.5. Cardiogenic shock
    • 7.3.3. ECPR
  • 7.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Application, 2024-2032

8. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 8.1. Introduction
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. East Asia
    • 8.3.5. South Asia
    • 8.3.6. Oceania
    • 8.3.7. MEA
  • 8.4. Market Attractiveness Analysis By Region

9. North America Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 9.2.1. By Country
      • 9.2.1.1. U.S.
      • 9.2.1.2. Canada
    • 9.2.2. By Product Type
    • 9.2.3. By Age Group
    • 9.2.4. By Application
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Age Group
    • 9.3.4. By Application
  • 9.4. Key Takeaways

10. Latin America Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. Brazil
      • 10.2.1.2. Mexico
      • 10.2.1.3. Argentina
      • 10.2.1.4. Rest of Latin America
    • 10.2.2. By Product Type
    • 10.2.3. By Age Group
    • 10.2.4. By Application
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By Age Group
    • 10.3.4. By Application
  • 10.4. Key Takeaways

11. Europe Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Germany
      • 11.2.1.2. Italy
      • 11.2.1.3. France
      • 11.2.1.4. U.K.
      • 11.2.1.5. Spain
      • 11.2.1.6. Russia
      • 11.2.1.7. BENELUX
      • 11.2.1.8. Rest of Europe
    • 11.2.2. By Product Type
    • 11.2.3. By Age Group
    • 11.2.4. By Application
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product Type
    • 11.3.3. By Age Group
    • 11.3.4. By Application
  • 11.4. Key Takeaways

12. East Asia Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. China
      • 12.2.1.2. Japan
      • 12.2.1.3. South Korea
    • 12.2.2. By Product Type
    • 12.2.3. By Age Group
    • 12.2.4. By Application
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product Type
    • 12.3.3. By Age Group
    • 12.3.4. By Application
  • 12.4. Key Takeaways

13. South Asia Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. India
      • 13.2.1.2. Thailand
      • 13.2.1.3. Malaysia
      • 13.2.1.4. Indonesia
      • 13.2.1.5. Rest of South Asia
    • 13.2.2. By Product Type
    • 13.2.3. By Age Group
    • 13.2.4. By Application
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product Type
    • 13.3.3. By Age Group
    • 13.3.4. By Application
  • 13.4. Key Takeaways

14. Oceania Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. Australia
      • 14.2.1.2. New Zealand
    • 14.2.2. By Product Type
    • 14.2.3. By Age Group
    • 14.2.4. By Application
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product Type
    • 14.3.3. By Age Group
    • 14.3.4. By Application
  • 14.4. Key Takeaways

15. MEA Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 15.2.1. By Country
      • 15.2.1.1. GCC
      • 15.2.1.2. Rest of MEA
    • 15.2.2. By Product Type
    • 15.2.3. By Age Group
    • 15.2.4. By Application
  • 15.3. Market Attractiveness Analysis
    • 15.3.1. By Country
    • 15.3.2. By Product Type
    • 15.3.3. By Age Group
    • 15.3.4. By Application
  • 15.4. Key Takeaways

16. Key Countries Membrane Oxygenators Market Analysis

  • 16.1. U.S.
    • 16.1.1. Pricing Analysis
    • 16.1.2. Market Share Analysis, 2024
      • 16.1.2.1. By Product Type
      • 16.1.2.2. By Age Group
      • 16.1.2.3. By Application
  • 16.2. Canada
    • 16.2.1. Pricing Analysis
    • 16.2.2. Market Share Analysis, 2024
      • 16.2.2.1. By Product Type
      • 16.2.2.2. By Age Group
      • 16.2.2.3. By Application
  • 16.3. Brazil
    • 16.3.1. Pricing Analysis
    • 16.3.2. Market Share Analysis, 2024
      • 16.3.2.1. By Product Type
      • 16.3.2.2. By Age Group
      • 16.3.2.3. By Application
  • 16.4. Mexico
    • 16.4.1. Pricing Analysis
    • 16.4.2. Market Share Analysis, 2024
      • 16.4.2.1. By Product Type
      • 16.4.2.2. By Age Group
      • 16.4.2.3. By Application
  • 16.5. Argentina
    • 16.5.1. Pricing Analysis
    • 16.5.2. Market Share Analysis, 2024
      • 16.5.2.1. By Product Type
      • 16.5.2.2. By Age Group
      • 16.5.2.3. By Application
  • 16.6. Germany
    • 16.6.1. Pricing Analysis
    • 16.6.2. Market Share Analysis, 2024
      • 16.6.2.1. By Product Type
      • 16.6.2.2. By Age Group
      • 16.6.2.3. By Application
  • 16.7. Italy
    • 16.7.1. Pricing Analysis
    • 16.7.2. Market Share Analysis, 2024
      • 16.7.2.1. By Product Type
      • 16.7.2.2. By Age Group
      • 16.7.2.3. By Application
  • 16.8. France
    • 16.8.1. Pricing Analysis
    • 16.8.2. Market Share Analysis, 2024
      • 16.8.2.1. By Product Type
      • 16.8.2.2. By Age Group
      • 16.8.2.3. By Application
  • 16.9. U.K.
    • 16.9.1. Pricing Analysis
    • 16.9.2. Market Share Analysis, 2024
      • 16.9.2.1. By Product Type
      • 16.9.2.2. By Age Group
      • 16.9.2.3. By Application
  • 16.10. Spain
    • 16.10.1. Pricing Analysis
    • 16.10.2. Market Share Analysis, 2024
      • 16.10.2.1. By Product Type
      • 16.10.2.2. By Age Group
      • 16.10.2.3. By Application
  • 16.11. Russia
    • 16.11.1. Pricing Analysis
    • 16.11.2. Market Share Analysis, 2024
      • 16.11.2.1. By Product Type
      • 16.11.2.2. By Age Group
      • 16.11.2.3. By Application
  • 16.12. BENELUX
    • 16.12.1. Pricing Analysis
    • 16.12.2. Market Share Analysis, 2024
      • 16.12.2.1. By Product Type
      • 16.12.2.2. By Age Group
      • 16.12.2.3. By Application
  • 16.13. China
    • 16.13.1. Pricing Analysis
    • 16.13.2. Market Share Analysis, 2024
      • 16.13.2.1. By Product Type
      • 16.13.2.2. By Age Group
      • 16.13.2.3. By Application
  • 16.14. Japan
    • 16.14.1. Pricing Analysis
    • 16.14.2. Market Share Analysis, 2024
      • 16.14.2.1. By Product Type
      • 16.14.2.2. By Age Group
      • 16.14.2.3. By Application
  • 16.15. South Korea
    • 16.15.1. Pricing Analysis
    • 16.15.2. Market Share Analysis, 2024
      • 16.15.2.1. By Product Type
      • 16.15.2.2. By Age Group
      • 16.15.2.3. By Application
  • 16.16. India
    • 16.16.1. Pricing Analysis
    • 16.16.2. Market Share Analysis, 2024
      • 16.16.2.1. By Product Type
      • 16.16.2.2. By Age Group
      • 16.16.2.3. By Application
  • 16.17. Thailand
    • 16.17.1. Pricing Analysis
    • 16.17.2. Market Share Analysis, 2024
      • 16.17.2.1. By Product Type
      • 16.17.2.2. By Age Group
      • 16.17.2.3. By Application
  • 16.18. Malaysia
    • 16.18.1. Pricing Analysis
    • 16.18.2. Market Share Analysis, 2024
      • 16.18.2.1. By Product Type
      • 16.18.2.2. By Age Group
      • 16.18.2.3. By Application
  • 16.19. Indonesia
    • 16.19.1. Pricing Analysis
    • 16.19.2. Market Share Analysis, 2024
      • 16.19.2.1. By Product Type
      • 16.19.2.2. By Age Group
      • 16.19.2.3. By Application
  • 16.20. Australia
    • 16.20.1. Pricing Analysis
    • 16.20.2. Market Share Analysis, 2024
      • 16.20.2.1. By Product Type
      • 16.20.2.2. By Age Group
      • 16.20.2.3. By Application
  • 16.21. New Zealand
    • 16.21.1. Pricing Analysis
    • 16.21.2. Market Share Analysis, 2024
      • 16.21.2.1. By Product Type
      • 16.21.2.2. By Age Group
      • 16.21.2.3. By Application
  • 16.22. GCC Countries
    • 16.22.1. Pricing Analysis
    • 16.22.2. Market Share Analysis, 2024
      • 16.22.2.1. By Product Type
      • 16.22.2.2. By Age Group
      • 16.22.2.3. By Application

17. Market Structure Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competition Benchmarking
  • 17.3. Market Share Analysis of Top Players
    • 17.3.1. By Regional
    • 17.3.2. By Product Type
    • 17.3.3. By Age Group
    • 17.3.4. By Application

18. Competition Analysis

  • 18.1. Competition Deep Dive
    • 18.1.1. MicroPort Scientific Corporation
      • 18.1.1.1. Overview
      • 18.1.1.2. Product Portfolio
      • 18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.1.4. Sales Footprint
      • 18.1.1.5. Strategy Overview
        • 18.1.1.5.1. Marketing Strategy
        • 18.1.1.5.2. Product Strategy
        • 18.1.1.5.3. Channel Strategy
    • 18.1.2. Nipro Medical Corporation
      • 18.1.2.1. Overview
      • 18.1.2.2. Product Portfolio
      • 18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.2.4. Sales Footprint
      • 18.1.2.5. Strategy Overview
        • 18.1.2.5.1. Marketing Strategy
        • 18.1.2.5.2. Product Strategy
        • 18.1.2.5.3. Channel Strategy
    • 18.1.3. Medtronic
      • 18.1.3.1. Overview
      • 18.1.3.2. Product Portfolio
      • 18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.3.4. Sales Footprint
      • 18.1.3.5. Strategy Overview
        • 18.1.3.5.1. Marketing Strategy
        • 18.1.3.5.2. Product Strategy
        • 18.1.3.5.3. Channel Strategy
    • 18.1.4. Fresenius SE & Co KGaA
      • 18.1.4.1. Overview
      • 18.1.4.2. Product Portfolio
      • 18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.4.4. Sales Footprint
      • 18.1.4.5. Strategy Overview
        • 18.1.4.5.1. Marketing Strategy
        • 18.1.4.5.2. Product Strategy
        • 18.1.4.5.3. Channel Strategy
    • 18.1.5. Terumo Medical Corporation
      • 18.1.5.1. Overview
      • 18.1.5.2. Product Portfolio
      • 18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.5.4. Sales Footprint
      • 18.1.5.5. Strategy Overview
        • 18.1.5.5.1. Marketing Strategy
        • 18.1.5.5.2. Product Strategy
        • 18.1.5.5.3. Channel Strategy
    • 18.1.6. Getinge AB
      • 18.1.6.1. Overview
      • 18.1.6.2. Product Portfolio
      • 18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.6.4. Sales Footprint
      • 18.1.6.5. Strategy Overview
        • 18.1.6.5.1. Marketing Strategy
        • 18.1.6.5.2. Product Strategy
        • 18.1.6.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology